This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsRe:NewCell (6QP) 주식 개요Re:NewCell AB (publ) operates as a textile recycling company in Sweden. 자세히 보기6QP 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장2/6과거 실적0/6재무 건전성1/6배당0/6강점수익은 연간 82.95% 증가할 것으로 예상됩니다.위험 분석cash runway 경력이 1년 미만입니다.지난 3개월 동안 주가 변동성이 German 시장과 비교했을 때 매우 높았습니다.현재 수익성이 없으며 향후 3년 동안 수익을 낼 것으로 예상되지 않습니다.지난 1년 동안 주주가 희석되었습니다.+ 위험 1건 추가모든 위험 점검 보기6QP Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.4593.9% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-912m4b2016201920222025202620282031Revenue SEK 4.2bEarnings SEK 394.6mAdvancedSet Fair ValueView all narrativesRe:NewCell AB (publ) 경쟁사IBU-tec advanced materialsSymbol: XTRA:IBUMarket cap: €77.2mSIMONASymbol: DB:SIM0Market cap: €300.0mOTI GreentechSymbol: DUSE:NSAKMarket cap: €311.5kPPK GroupSymbol: ASX:PPKMarket cap: AU$28.1m가격 이력 및 성과Re:NewCell 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가SEK 0.4552주 최고가SEK 8.2452주 최저가SEK 0.40베타1.61개월 변동-49.04%3개월 변동-30.56%1년 변동-94.32%3년 변동-98.13%5년 변동n/aIPO 이후 변동-96.13%최근 뉴스 및 업데이트공시 • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.공시 • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.공시 • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).공시 • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.더 많은 업데이트 보기Recent updates공시 • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.공시 • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.공시 • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).공시 • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 24Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Reported Earnings • Nov 08Third quarter 2023 earnings released: kr2.31 loss per share (vs kr2.99 loss in 3Q 2022)Third quarter 2023 results: kr2.31 loss per share (improved from kr2.99 loss in 3Q 2022). Revenue: kr86.1m (up kr83.1m from 3Q 2022). Net loss: kr94.5m (loss narrowed 6.9% from 3Q 2022). Revenue is forecast to grow 82% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.New Risk • Nov 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings are forecast to decline by an average of 1.4% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr107m net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€35.4m market cap, or US$37.8m).공시 • Nov 07Re:NewCell AB (publ) to Report Fiscal Year 2023 Final Results on Apr 26, 2024Re:NewCell AB (publ) announced that they will report fiscal year 2023 final results on Apr 26, 2024공시 • Oct 18Re:NewCell AB (publ) Announces CEO ChangesRe:NewCell AB (publ) announced that the Board has appointed Magnus Håkansson as the new acting CEO. Magnus has solid experience from leading roles in the retail and fashion sector and from leadership in a listed environment. He will start on October 16, 2023 and replaces Patrik Lundström, who has been the company's CEO since 2019. Magnus Håkansson was born in 1963, has a degree in economics from the Stockholm School of Economics and an MBA from MIT Sloan School of Management. He started his career as a management consultant at McKinsey and has since held several leading roles in global growth companies in the retail sector, as well as the pulp industry, including many years with experience from a listed environment. He most recently came from a role as CEO of MediaMarkt Sweden.Breakeven Date Change • Oct 16Forecast breakeven date pushed back to 2025The 3 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 52% per year to 2024. The company is expected to make a profit of kr378.3m in 2025. Average annual earnings growth of 104% is required to achieve expected profit on schedule.New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €49.0m (US$51.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Significant insider selling over the past 3 months (€1.4m sold). Market cap is less than US$100m (€49.0m market cap, or US$51.4m).공시 • Oct 13Re:Newcell AB (Publ) Provides Earnings Guidance for the Third Quarter of 2023Re:NewCell AB (publ) provided earnings guidance for the third quarter of 2023. For the quarter, the company expected to report Net loss of approximately SEK 105 million.Recent Insider Transactions • Oct 10CEO & MD recently sold €299k worth of stockOn the 6th of October, Patrik Lundstrom sold around 109k shares on-market at roughly €2.74 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €1.4m. Patrik has been a net seller over the last 12 months, reducing personal holdings by €1.7m.Reported Earnings • Aug 30Second quarter 2023 earnings released: kr2.82 loss per share (vs kr2.09 loss in 2Q 2022)Second quarter 2023 results: kr2.82 loss per share (further deteriorated from kr2.09 loss in 2Q 2022). Revenue: kr86.0m (up kr83.5m from 2Q 2022). Net loss: kr105.4m (loss widened 54% from 2Q 2022). Revenue is forecast to grow 78% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.공시 • Aug 30+ 2 more updatesRe:NewCell AB (publ) to Report Q4, 2023 Results on Feb 13, 2024Re:NewCell AB (publ) announced that they will report Q4, 2023 results on Feb 13, 2024Breakeven Date Change • Aug 24Forecast breakeven date pushed back to 2025The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr233.9m in 2025. Average annual earnings growth of 73% is required to achieve expected profit on schedule.Recent Insider Transactions • Aug 01CEO & MD recently sold €1.4m worth of stockOn the 27th of July, Patrik Lundstrom sold around 224k shares on-market at roughly €6.20 per share. This transaction amounted to 33% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.공시 • Jul 17Re:NewCell AB (publ) Announces Toby Lawton to Leave His Position as CFORe:NewCell AB (publ) Toby Lawton, CFO at Renewcell AB (publ), has announced that he will leave his position for a similar position in another company. Toby will continue to work as CFO until a successor has been appointed or at the latest until the end of the year.공시 • Jul 01Re:Newcell AB (Publ) Provides Production from Renewcell 1 Guidance in June 2023Re:NewCell AB (publ) provided production from Renewcell 1 guidance in June 2023. Production from Renewcell 1 is expected to reach 2,200-2,400 metric tons in June 2023, of which 2,100-2,300 metric tons are expected to be of prime quality and 2,200-2,400 metric tons are expected to be delivered to customers. The production in the month has been impacted by maintenance stops to upgrade and install new equipment in the shredding area.Reported Earnings • Apr 30Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.공시 • Feb 16+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2023 Results on Nov 07, 2023Re:NewCell AB (publ) announced that they will report Q3, 2023 results on Nov 07, 2023Reported Earnings • Feb 16Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.Breakeven Date Change • Feb 08Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr51.6m in 2024. Average annual earnings growth of 66% is required to achieve expected profit on schedule.Breakeven Date Change • Nov 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 22% per year to 2023. The company is expected to make a profit of kr118.9m in 2024. Average annual earnings growth of 72% is required to achieve expected profit on schedule.Board Change • Nov 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Nov 04Re:Newcell AB (Publ) Appoints Tricia Carey as Chief Commercial OfficerRe:NewCell AB (publ) strengthens its commercial team with the addition of Tricia Carey as Chief Commercial Officer. Mrs. Carey is a seasoned fashion industry executive with more than 25 years of experience promoting more circular and more sustainable materials within fashion. She has also been a catalyst for the industry-wide conversation around the shift to more climate-friendly and resource-efficient materials as a board member at Textile Exchange and Accelerating Circularity. Prior to joining Renewcell, Mrs. Carey held the position of Director of Global Business Development at the leading Austrian fiber producer Lenzing. About Tricia Carey: Throughout her career, Tricia believes in ‘progress over perfection'. As an advocate for innovation and circularity in the textile and apparel industry, she recently joined Renewcell to accelerate the commercial development of Circulose®, making fashion circular. With a vast global network, as well as experience in brand building, and business development, she will be an important partner to close the loop and optimize the benefits of Circulose®. For more than twenty years, Tricia held various commercial management positions at Lenzing Fibers to establish the TENCEL™ brand, build mill partners and set retailer specifications. Her roles comprised marketing, Americas business development, and global denim segment expansion including the creation of the Carved in Blue platform and numerous collaborative collections with mills and brands. Tricia holds a bachelor's degree in Fashion Merchandising from The Fashion Institute of Technology, as well as certificates in Digital Marketing and Strategy from Cornell University and MIT.Reported Earnings • Oct 29Third quarter 2022 earnings released: kr2.99 loss per share (vs kr0.80 loss in 3Q 2021)Third quarter 2022 results: kr2.99 loss per share (further deteriorated from kr0.80 loss in 3Q 2021). Net loss: kr101.5m (loss widened 314% from 3Q 2021). Revenue is forecast to grow 82% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.Breakeven Date Change • Oct 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of kr122.1m in 2024. Average annual earnings growth of 75% is required to achieve expected profit on schedule.공시 • Oct 28+ 1 more updateRe:NewCell AB (publ) to Report Q2, 2023 Results on Aug 18, 2023Re:NewCell AB (publ) announced that they will report Q2, 2023 results on Aug 18, 2023Reported Earnings • Aug 27Second quarter 2022 earnings released: kr2.09 loss per share (vs kr0.76 loss in 2Q 2021)Second quarter 2022 results: kr2.09 loss per share (down from kr0.76 loss in 2Q 2021). Net loss: kr68.4m (loss widened 192% from 2Q 2021). Over the next year, revenue is forecast to grow 3,859%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.공시 • Jul 05Re:NewCell AB Appoints Toby Lawton as New Chief Financial Officer, Effective October 1, 2022Re:NewCell AB (publ) announced that Toby Lawton will join the company in the role of Chief Financial Officer. He comes from a role as CFO at SCA, a position he has held for the past five years. Toby brings extensive experience from leadership positions over a two decade career with the publicly listed companies Svenska Cellulosa AB (SCA) in Sweden and Vinda International in Hong Kong. His expertise in financing large scale international projects and operational management within pulp and paper and consumer products industries will strengthen Renewcell’s scaling efforts. Toby Lawton will assume his new position at Renewcell on October 1, 2022. Hugo Petit, Renewcell’s current CFO, will remain as CFO until October 1, 2022.Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • May 18Re:Newcell AB (Publ) Announces Executive ChangesRe:NewCell AB (publ) announced that at its Annual General Meeting held on 17 May 2022 elected Michael Berg as members of the Board of Directors for the period until the end of the next Annual General Meeting. It was noted that Mia Hemmingson has declined re-election as Chairman of the Board. Michael Berg was elected Chairman of the Board.Reported Earnings • May 05First quarter 2022 earnings released: kr1.75 loss per share (vs kr0.63 loss in 1Q 2021)First quarter 2022 results: kr1.75 loss per share (down from kr0.63 loss in 1Q 2021). Net loss: kr54.0m (loss widened 181% from 1Q 2021). Over the next year, revenue is forecast to grow 4,106%, compared to a 8.5% growth forecast for the industry in Germany.공시 • May 05Re:NewCell AB (publ) to Report Q1, 2023 Results on May 03, 2023Re:NewCell AB (publ) announced that they will report Q1, 2023 results on May 03, 2023Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Breakeven Date Change • Mar 09Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Feb 19Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Reported Earnings • Feb 17Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: kr4.33 loss per share (down from kr3.34 loss in FY 2020). Net loss: kr133.4m (loss widened 94% from FY 2020). Revenue exceeded analyst estimates by 10%. Over the next year, revenue is forecast to grow 1,979%, compared to a 6.5% growth forecast for the industry in Germany.공시 • Feb 17Re:NewCell AB (publ) to Report Q4, 2022 Results on Feb 15, 2023Re:NewCell AB (publ) announced that they will report Q4, 2022 results on Feb 15, 2023공시 • Feb 16Re:NewCell AB (publ) Provides Production Guidance for the Year 2022Re:NewCell AB (publ) provided production guidance for the year 2022. The company expects production of 60,000 metric tons.공시 • Feb 07+ 2 more updatesRe:NewCell AB (publ), Annual General Meeting, May 17, 2022Re:NewCell AB (publ), Annual General Meeting, May 17, 2022.Breakeven Date Change • Jan 28Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Jan 07Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.Reported Earnings • Nov 07Third quarter 2021 earnings released: kr0.80 loss per share (vs kr0.81 loss in 3Q 2020)Third quarter 2021 results: Net loss: kr24.5m (loss widened 55% from 3Q 2020).Recent Insider Transactions • Jun 25Plant Manager Ortviken recently bought €11k worth of stockOn the 21st of June, Henrik Dahlbom bought around 700 shares on-market at roughly €15.19 per share. In the last 3 months, there was an even bigger purchase from another insider worth €51k. Insiders have collectively bought €148k more in shares than they have sold in the last 12 months.Recent Insider Transactions • Jun 13Chief Executive Officer recently bought €51k worth of stockOn the 11th of June, Patrik Lundstrom bought around 3k shares on-market at roughly €18.20 per share. This was the largest purchase by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.Executive Departure • May 22Director has left the companyOn the 19th of May, Erik Karlsson's tenure in the role of Director ended. We don't have any record of a personal shareholding under Erik's name. A total of 3 executives have left over the last 12 months.Executive Departure • May 22Director has left the companyOn the 19th of May, Henrik Norlin's tenure in the role of Director ended. We don't have any record of a personal shareholding under Henrik's name. A total of 3 executives have left over the last 12 months.Reported Earnings • May 05First quarter 2021 earnings releasedFirst quarter 2021 results: Net loss: kr19.3m (loss widened 58% from 1Q 2020).공시 • Mar 05Renewcell Awarded Afry an Engineering Assignment for Their Recycled Textile Materials Production Expansion at Sca's Ortviken Paper Mill in Sundsvall, SwedenRenewcell has awarded AFRY an engineering assignment for their recycled textile materials production expansion at SCA's Ortviken paper mill in Sundsvall, Sweden. The assignment includes project and construction management services, process, mechanical and piping engineering, electrical, automation and instrumentation engineering, fire and HVAC design, as well as civil design. The project is a continuation of AFRY's previous feasibility studies. The trend in textiles and design requires sustainable fashion. Customers require fashion companies to reduce their environmental impact through new technologies and innovations for the circular economy. One important element is recycling of textile fibers that is a path towards a more sustainable fashion.주주 수익률6QPDE ChemicalsDE 시장7D0.8%-0.3%3.2%1Y-94.3%5.7%2.5%전체 주주 수익률 보기수익률 대 산업: 6QP은 지난 1년 동안 5.7%의 수익을 기록한 German Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 6QP은 지난 1년 동안 2.5%를 기록한 German 시장보다 저조한 성과를 냈습니다.주가 변동성Is 6QP's price volatile compared to industry and market?6QP volatility6QP Average Weekly Movement13.2%Chemicals Industry Average Movement6.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%안정적인 주가: 6QP의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: 6QP의 주간 변동성은 지난 1년간 18%에서 13%로 감소했지만 여전히 German 종목의 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트2012123Magnus Håkanssonwww.renewcell.com더 보기Re:NewCell AB (publ) 기초 지표 요약Re:NewCell의 순이익과 매출은 시가총액과 어떻게 비교됩니까?6QP 기초 통계시가총액€19.54m순이익 (TTM)-€35.80m매출 (TTM)€18.30m1.1x주가매출비율(P/S)-0.5x주가수익비율(P/E)6QP는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표6QP 손익계산서 (TTM)매출SEK 205.18m매출원가SEK 288.15m총이익-SEK 82.97m기타 비용SEK 318.38m순이익-SEK 401.35m최근 보고된 실적Sep 30, 2023다음 실적 발표일Apr 26, 2024주당순이익(EPS)-9.71총이익률-40.44%순이익률-195.60%부채/자본 비율102.7%6QP의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/02/29 18:54종가2024/02/29 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Re:NewCell AB (publ)는 2명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Daniel OvinNordea MarketsJohan SpetzPareto Securities
공시 • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.
공시 • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.
공시 • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024
New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).
공시 • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.
Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
공시 • Jun 05Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ).Altor Equity Partners AB acquired Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.Altor Equity Partners AB completed the acquisition of Remaining Assets of Re:NewCell AB (publ) from Re:NewCell AB (publ) on June 4, 2024.
공시 • Jan 10Re:NewCell AB Plans for Restructuring to Strengthen Organization Within Continuous Focus on SalesRe:NewCell AB announced that they are planning to start negotiations with the relevant trade unions regarding restructuring of the organization to improve efficiency while maintaining focus on sales. As part of the restructuring, the local authorities (Arbetsförmedlingen) will also be notified today. The planned restructuring will lead to a decrease in workforce of approximately 25%, just over 30 persons, and will also result in annual savings - reduction of personnel cost and other operating costs - of approximately 35 SEKm in total per annum when finalized.
공시 • Dec 23+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2024 Results on Nov 06, 2024Re:NewCell AB (publ) announced that they will report Q3, 2024 results on Nov 06, 2024
New Risk • Dec 23New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: kr401m Forecast net loss in 2 years: kr27m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr578m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr27m net loss in 2 years). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€32.0m market cap, or US$35.3m).
공시 • Dec 13Peter Schulz Joins as Interim CFO at Re:NewCell AB (publ) Effective 1 January 2024Re:NewCell AB (publ) announced Peter Schulz will join the company in the role of interim Chief Financial Officer (CFO) from 1 January 2024. He comes from a role as CFO at Pacific Basin Shipping (publ.) in Hong Kong, a position he has held for the past six years. Peter Schulz has extensive experience as CFO from both listed and private companies for the last 10 years. Prior to that Peter Schulz spent more than 15 years, and held senior positions, in investment banking in Stockholm, London and Hong Kong, among others with Royal Bank of Canada and ABN Amro. With his extensive and broad experience, he will contribute well to the management team and the company.
Breakeven Date Change • Nov 25Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 24Forecast to breakeven in 2025The 3 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 30% per year to 2024. The company is expected to make a profit of kr12.8m in 2025. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Reported Earnings • Nov 08Third quarter 2023 earnings released: kr2.31 loss per share (vs kr2.99 loss in 3Q 2022)Third quarter 2023 results: kr2.31 loss per share (improved from kr2.99 loss in 3Q 2022). Revenue: kr86.1m (up kr83.1m from 3Q 2022). Net loss: kr94.5m (loss narrowed 6.9% from 3Q 2022). Revenue is forecast to grow 82% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany.
New Risk • Nov 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (29% average weekly change). Earnings are forecast to decline by an average of 1.4% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr107m net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€35.4m market cap, or US$37.8m).
공시 • Nov 07Re:NewCell AB (publ) to Report Fiscal Year 2023 Final Results on Apr 26, 2024Re:NewCell AB (publ) announced that they will report fiscal year 2023 final results on Apr 26, 2024
공시 • Oct 18Re:NewCell AB (publ) Announces CEO ChangesRe:NewCell AB (publ) announced that the Board has appointed Magnus Håkansson as the new acting CEO. Magnus has solid experience from leading roles in the retail and fashion sector and from leadership in a listed environment. He will start on October 16, 2023 and replaces Patrik Lundström, who has been the company's CEO since 2019. Magnus Håkansson was born in 1963, has a degree in economics from the Stockholm School of Economics and an MBA from MIT Sloan School of Management. He started his career as a management consultant at McKinsey and has since held several leading roles in global growth companies in the retail sector, as well as the pulp industry, including many years with experience from a listed environment. He most recently came from a role as CEO of MediaMarkt Sweden.
Breakeven Date Change • Oct 16Forecast breakeven date pushed back to 2025The 3 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 52% per year to 2024. The company is expected to make a profit of kr378.3m in 2025. Average annual earnings growth of 104% is required to achieve expected profit on schedule.
New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €49.0m (US$51.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr786m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Significant insider selling over the past 3 months (€1.4m sold). Market cap is less than US$100m (€49.0m market cap, or US$51.4m).
공시 • Oct 13Re:Newcell AB (Publ) Provides Earnings Guidance for the Third Quarter of 2023Re:NewCell AB (publ) provided earnings guidance for the third quarter of 2023. For the quarter, the company expected to report Net loss of approximately SEK 105 million.
Recent Insider Transactions • Oct 10CEO & MD recently sold €299k worth of stockOn the 6th of October, Patrik Lundstrom sold around 109k shares on-market at roughly €2.74 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €1.4m. Patrik has been a net seller over the last 12 months, reducing personal holdings by €1.7m.
Reported Earnings • Aug 30Second quarter 2023 earnings released: kr2.82 loss per share (vs kr2.09 loss in 2Q 2022)Second quarter 2023 results: kr2.82 loss per share (further deteriorated from kr2.09 loss in 2Q 2022). Revenue: kr86.0m (up kr83.5m from 2Q 2022). Net loss: kr105.4m (loss widened 54% from 2Q 2022). Revenue is forecast to grow 78% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany.
공시 • Aug 30+ 2 more updatesRe:NewCell AB (publ) to Report Q4, 2023 Results on Feb 13, 2024Re:NewCell AB (publ) announced that they will report Q4, 2023 results on Feb 13, 2024
Breakeven Date Change • Aug 24Forecast breakeven date pushed back to 2025The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr233.9m in 2025. Average annual earnings growth of 73% is required to achieve expected profit on schedule.
Recent Insider Transactions • Aug 01CEO & MD recently sold €1.4m worth of stockOn the 27th of July, Patrik Lundstrom sold around 224k shares on-market at roughly €6.20 per share. This transaction amounted to 33% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.
공시 • Jul 17Re:NewCell AB (publ) Announces Toby Lawton to Leave His Position as CFORe:NewCell AB (publ) Toby Lawton, CFO at Renewcell AB (publ), has announced that he will leave his position for a similar position in another company. Toby will continue to work as CFO until a successor has been appointed or at the latest until the end of the year.
공시 • Jul 01Re:Newcell AB (Publ) Provides Production from Renewcell 1 Guidance in June 2023Re:NewCell AB (publ) provided production from Renewcell 1 guidance in June 2023. Production from Renewcell 1 is expected to reach 2,200-2,400 metric tons in June 2023, of which 2,100-2,300 metric tons are expected to be of prime quality and 2,200-2,400 metric tons are expected to be delivered to customers. The production in the month has been impacted by maintenance stops to upgrade and install new equipment in the shredding area.
Reported Earnings • Apr 30Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.
공시 • Feb 16+ 1 more updateRe:NewCell AB (publ) to Report Q3, 2023 Results on Nov 07, 2023Re:NewCell AB (publ) announced that they will report Q3, 2023 results on Nov 07, 2023
Reported Earnings • Feb 16Full year 2022 earnings released: kr8.99 loss per share (vs kr4.33 loss in FY 2021)Full year 2022 results: kr8.99 loss per share (further deteriorated from kr4.33 loss in FY 2021). Net loss: kr299.9m (loss widened 125% from FY 2021). Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.
Breakeven Date Change • Feb 08Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr51.6m in 2024. Average annual earnings growth of 66% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 22% per year to 2023. The company is expected to make a profit of kr118.9m in 2024. Average annual earnings growth of 72% is required to achieve expected profit on schedule.
Board Change • Nov 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Nov 04Re:Newcell AB (Publ) Appoints Tricia Carey as Chief Commercial OfficerRe:NewCell AB (publ) strengthens its commercial team with the addition of Tricia Carey as Chief Commercial Officer. Mrs. Carey is a seasoned fashion industry executive with more than 25 years of experience promoting more circular and more sustainable materials within fashion. She has also been a catalyst for the industry-wide conversation around the shift to more climate-friendly and resource-efficient materials as a board member at Textile Exchange and Accelerating Circularity. Prior to joining Renewcell, Mrs. Carey held the position of Director of Global Business Development at the leading Austrian fiber producer Lenzing. About Tricia Carey: Throughout her career, Tricia believes in ‘progress over perfection'. As an advocate for innovation and circularity in the textile and apparel industry, she recently joined Renewcell to accelerate the commercial development of Circulose®, making fashion circular. With a vast global network, as well as experience in brand building, and business development, she will be an important partner to close the loop and optimize the benefits of Circulose®. For more than twenty years, Tricia held various commercial management positions at Lenzing Fibers to establish the TENCEL™ brand, build mill partners and set retailer specifications. Her roles comprised marketing, Americas business development, and global denim segment expansion including the creation of the Carved in Blue platform and numerous collaborative collections with mills and brands. Tricia holds a bachelor's degree in Fashion Merchandising from The Fashion Institute of Technology, as well as certificates in Digital Marketing and Strategy from Cornell University and MIT.
Reported Earnings • Oct 29Third quarter 2022 earnings released: kr2.99 loss per share (vs kr0.80 loss in 3Q 2021)Third quarter 2022 results: kr2.99 loss per share (further deteriorated from kr0.80 loss in 3Q 2021). Net loss: kr101.5m (loss widened 314% from 3Q 2021). Revenue is forecast to grow 82% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat.
Breakeven Date Change • Oct 29Forecast breakeven date pushed back to 2024The 2 analysts covering Re:NewCell previously expected the company to break even in 2023. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of kr122.1m in 2024. Average annual earnings growth of 75% is required to achieve expected profit on schedule.
공시 • Oct 28+ 1 more updateRe:NewCell AB (publ) to Report Q2, 2023 Results on Aug 18, 2023Re:NewCell AB (publ) announced that they will report Q2, 2023 results on Aug 18, 2023
Reported Earnings • Aug 27Second quarter 2022 earnings released: kr2.09 loss per share (vs kr0.76 loss in 2Q 2021)Second quarter 2022 results: kr2.09 loss per share (down from kr0.76 loss in 2Q 2021). Net loss: kr68.4m (loss widened 192% from 2Q 2021). Over the next year, revenue is forecast to grow 3,859%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.
공시 • Jul 05Re:NewCell AB Appoints Toby Lawton as New Chief Financial Officer, Effective October 1, 2022Re:NewCell AB (publ) announced that Toby Lawton will join the company in the role of Chief Financial Officer. He comes from a role as CFO at SCA, a position he has held for the past five years. Toby brings extensive experience from leadership positions over a two decade career with the publicly listed companies Svenska Cellulosa AB (SCA) in Sweden and Vinda International in Hong Kong. His expertise in financing large scale international projects and operational management within pulp and paper and consumer products industries will strengthen Renewcell’s scaling efforts. Toby Lawton will assume his new position at Renewcell on October 1, 2022. Hugo Petit, Renewcell’s current CFO, will remain as CFO until October 1, 2022.
Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • May 18Re:Newcell AB (Publ) Announces Executive ChangesRe:NewCell AB (publ) announced that at its Annual General Meeting held on 17 May 2022 elected Michael Berg as members of the Board of Directors for the period until the end of the next Annual General Meeting. It was noted that Mia Hemmingson has declined re-election as Chairman of the Board. Michael Berg was elected Chairman of the Board.
Reported Earnings • May 05First quarter 2022 earnings released: kr1.75 loss per share (vs kr0.63 loss in 1Q 2021)First quarter 2022 results: kr1.75 loss per share (down from kr0.63 loss in 1Q 2021). Net loss: kr54.0m (loss widened 181% from 1Q 2021). Over the next year, revenue is forecast to grow 4,106%, compared to a 8.5% growth forecast for the industry in Germany.
공시 • May 05Re:NewCell AB (publ) to Report Q1, 2023 Results on May 03, 2023Re:NewCell AB (publ) announced that they will report Q1, 2023 results on May 03, 2023
Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Om Bhatia is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Breakeven Date Change • Mar 09Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Feb 19Forecast breakeven date moved forward to 2023The 2 analysts covering Re:NewCell previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of kr37.9m in 2023. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Reported Earnings • Feb 17Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: kr4.33 loss per share (down from kr3.34 loss in FY 2020). Net loss: kr133.4m (loss widened 94% from FY 2020). Revenue exceeded analyst estimates by 10%. Over the next year, revenue is forecast to grow 1,979%, compared to a 6.5% growth forecast for the industry in Germany.
공시 • Feb 17Re:NewCell AB (publ) to Report Q4, 2022 Results on Feb 15, 2023Re:NewCell AB (publ) announced that they will report Q4, 2022 results on Feb 15, 2023
공시 • Feb 16Re:NewCell AB (publ) Provides Production Guidance for the Year 2022Re:NewCell AB (publ) provided production guidance for the year 2022. The company expects production of 60,000 metric tons.
공시 • Feb 07+ 2 more updatesRe:NewCell AB (publ), Annual General Meeting, May 17, 2022Re:NewCell AB (publ), Annual General Meeting, May 17, 2022.
Breakeven Date Change • Jan 28Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Jan 07Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering Re:NewCell expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of kr5.77m in 2024. Average annual earnings growth of 59% is required to achieve expected profit on schedule.
Reported Earnings • Nov 07Third quarter 2021 earnings released: kr0.80 loss per share (vs kr0.81 loss in 3Q 2020)Third quarter 2021 results: Net loss: kr24.5m (loss widened 55% from 3Q 2020).
Recent Insider Transactions • Jun 25Plant Manager Ortviken recently bought €11k worth of stockOn the 21st of June, Henrik Dahlbom bought around 700 shares on-market at roughly €15.19 per share. In the last 3 months, there was an even bigger purchase from another insider worth €51k. Insiders have collectively bought €148k more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Jun 13Chief Executive Officer recently bought €51k worth of stockOn the 11th of June, Patrik Lundstrom bought around 3k shares on-market at roughly €18.20 per share. This was the largest purchase by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months.
Executive Departure • May 22Director has left the companyOn the 19th of May, Erik Karlsson's tenure in the role of Director ended. We don't have any record of a personal shareholding under Erik's name. A total of 3 executives have left over the last 12 months.
Executive Departure • May 22Director has left the companyOn the 19th of May, Henrik Norlin's tenure in the role of Director ended. We don't have any record of a personal shareholding under Henrik's name. A total of 3 executives have left over the last 12 months.
Reported Earnings • May 05First quarter 2021 earnings releasedFirst quarter 2021 results: Net loss: kr19.3m (loss widened 58% from 1Q 2020).
공시 • Mar 05Renewcell Awarded Afry an Engineering Assignment for Their Recycled Textile Materials Production Expansion at Sca's Ortviken Paper Mill in Sundsvall, SwedenRenewcell has awarded AFRY an engineering assignment for their recycled textile materials production expansion at SCA's Ortviken paper mill in Sundsvall, Sweden. The assignment includes project and construction management services, process, mechanical and piping engineering, electrical, automation and instrumentation engineering, fire and HVAC design, as well as civil design. The project is a continuation of AFRY's previous feasibility studies. The trend in textiles and design requires sustainable fashion. Customers require fashion companies to reduce their environmental impact through new technologies and innovations for the circular economy. One important element is recycling of textile fibers that is a path towards a more sustainable fashion.
